Typical antipsychotic
Pharmaceutical compound
| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.450 |
| Chemical and physical data | |
| Formula | C24H31N3OS |
| Molar mass | 409.59 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.[2] It was approved in 1967, and possibly discontinued in the 1980s.
Synthesis
[edit]
Butaperazine can be synthesized starting from 2-butyrylphenothiazine (1).[3] It is prepared in a manner that is comparable to the method used in the synthesis of propiomazine and propiopromazine.[clarification needed] The phenothiazine is alkylated with 1-(γ-chloropropyl)-4-methylpiperazine (2), which is prepared in the conventional way by alkylating 1-methylpiperazine with 1-bromo-3-chloropropane.
See also
[edit]References
[edit]- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ "Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate)". JAMA. 206 (10): 2307–8. December 1968. doi:10.1001/jama.206.10.2307. PMID 4386884.
- ^ Dr Ulrich Hoerlein, Dr Klaus-Heinz Risse, Dr Wolfgang Wirth, DE 1120451 (1961 to Bayer Ag).
| |||||||||||||||||||||||||
| D1-like |
| ||||||
|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||
| H1 |
| ||||
|---|---|---|---|---|---|
| H2 |
| ||||
| H3 |
| ||||
| H4 |
| ||||
| Classes | |
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs)) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Anticholinergics | |
| Others | |